CARGO Therapeutics Inc (CRGX): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of CARGO Therapeutics Inc is $209.53M. A total of 0.58 million shares were traded on the day, compared to an average of 1.17M shares.

In the most recent transaction, Radhakrishnan Anup sold 1,629 shares of CRGX for 4.00 per share on Apr 03 ’25. After the transaction, the insider now owns 77,317 company shares. In a previous transaction on Sep 18 ’24, Chapman Gina sold 7,166 shares at 25.09 per share. CRGX shares that President & CEO owns now total 103,905.

Among the insiders who sold shares, Chapman Gina disposed of 2,975 shares on Sep 19 ’24 at a per-share price of $25.03. This resulted in the President & CEO holding 103,905 shares of CRGX after the transaction. In another insider transaction, Radhakrishnan Anup sold 1,600 shares at $25.28 per share on Sep 18 ’24. Company shares held by the Chief Financial Officer now total 6,446.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CRGX has a high of $25.45 and a low of $3.00.

As of this writing, CRGX has an earnings estimate of -$0.57 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.73.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CRGX’s latest balance sheet shows that the firm has $41.00k in Cash & Short Term Investments as of fiscal 2021. There were $3.17M in debt and $2.45M in liabilities at the time. Its Book Value Per Share was $7.82, while its Total Shareholder’s Equity was -$175.00k.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRGX is Buy with a score of 2.60.

Most Popular

Related Posts